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Abstract In contrast to the human genome, the mouse genome
contains two HEPC genes encoding hepcidin, a key regulator of
iron homeostasis. Here we report a comparative analysis of se-
quence, genomic structure, expression and iron regulation of
mouse HEPC genes. The predicted processed 25 amino acid
hepcidin 2 peptide share 68% identity with hepcidin 1 with per-
fect conservation of eight cysteine residues. Both HEPC1 and
HEPC2 genes have similar genomic organization and have
probably arisen from a recent duplication of chromosome 7
region, including the HEPC ancestral gene and a part of the
adjacent USF2 gene. Insertion of a retroviral intracisternal
A-particle element was found upstream of the HEPC1 gene.
Both genes are highly expressed in the liver and to a much lesser
extent in the heart. In contrast to HEPC1, a high amount of
HEPC2 transcripts was detected in the pancreas. Expression of
both genes was increased in the liver during carbonyl^iron and
iron^dextran overload. Overall our data suggest that both
HEPC1 and HEPC2 genes are involved in iron metabolism
regulation but could exhibit di¡erent activities and/or play dis-
tinct roles.
4 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In search of hepatic genes induced during iron overload we
identi¢ed a novel mouse gene named HEPC [1] encoding a
small 83-amino-acid (aa) protein that shared signi¢cant ho-
mology in its C-terminal region with human cysteine-rich cir-
culating peptide hepcidin (also termed LEAP-1) isolated in
two parallel studies from human plasma ultra¢ltrate [2] and
urine [3]. Human hepcidin was reported to exhibit antibacte-
rial and antifungal activities [2,3]. However, in contrast to the
mammalian antimicrobial peptides described to date, it dis-
plays several original characteristics including a distinctive
cysteine structural motif. Speci¢cally, all eight cysteine resi-
dues of 25-aa hepcidin form intramolecular bonds, with six of
them involved in maintaining interstrand connectivity. One
unusual vicinal disul¢de bridge was suggested to have a func-
tional importance [4]. Another peculiar characteristic of hu-
man hepcidin is its predominant hepatic expression pattern
[1^3]. Similarly, mouse HEPC transcripts were found essen-
tially in the liver [1].
Besides its potential antimicrobial activity, recent reports
argue in favor of a role of hepcidin in iron metabolism. In-
deed, the analysis of upstream stimulatory factor 2 (USF2)
knockout mice lacking HEPC transcripts revealed a develop-
ment of iron overload in the liver, pancreas and heart [5].
Inversely, early liver expression of hepcidin in transgenic
mice resulted in phenotypic traits of iron de¢ciency [6]. These
observation support the idea that hepcidin is involved in the
regulation of iron homeostasis. By controlling the level of
duodenal iron absorption and iron release from macrophages,
hepcidin could act as a hormonal regulator of iron storage or
recycling [5,7]. Such a role of hepcidin in the regulation of
iron metabolism was con¢rmed in humans. Indeed, a refrac-
tory anemia similar to that observed in chronic in£ammatory
diseases was described in patients with large hepatic adenomas
overexpressing hepcidin [8]. Furthermore, mutations in the
HEPC gene were reported in two families with severe form
of juvenile hemochromatosis [9].
Only one hepcidin gene was found in the human genome.
However, a previous analysis of GenBank databases of mouse
expressed sequence tags (ESTs) and genomic sequences re-
vealed that in addition to the originally identi¢ed HEPC
gene, the mouse genome contains another highly related
gene named HEPC2 [1]. The presence of two mouse hepcidin
genes was con¢rmed subsequently [5]. One might expect,
based on the high degree of identity between HEPC1 and
HEPC2, that these two genes have a similar regulation and
are functionally redundant; however, it has not yet been dem-
onstrated formally. Considering that the mouse is a useful
animal model for the understanding of human iron metabo-
lism dysfunction [10] and that hepcidin plays an important
role in iron store regulation, we performed a comparative
analysis of sequences, genomic organization, expression and
iron regulation of mice HEPC1 and HEPC2 genes.
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2. Materials and methods
2.1. Animals
For experimental iron overload, 5-week-old BALB/cJ male mice
were obtained from CERJ (Le Genet, St Ile, France). Minced mice
liver samples were frozen in liquid nitrogen and kept at 380‡C until
further processing.
2.2. Iron overload
Carbonyl^iron and iron^dextran overloads were performed as pre-
viously described [1,11]. Brie£y, a group of ¢ve mice was iron over-
loaded by 3% carbonyl^iron supplemented in the diet (AO3, UAR,
France) during 8 months. Control mice had a carbonyl^iron-free diet.
For iron^dextran overload, a single subcutaneous injection of iron^
dextran (Sigma, France) was performed at a dose of 1 g/kg body
weight. Control mice received a single injection of a mixture contain-
ing dextran at the same concentration as in the iron^dextran solution.
Animals were killed 2 months after iron injection.
2.3. Determination of genomic organization of mouse HEPC1 and
HEPC2 genes
Mouse genomic clones CT7-8N15, RP23-22G9 and RP23-28D21
(GenBank accession numbers AC020841, AC087143 and AC021477,
respectively) were used to elucidate the genomic organization of
HEPC1, HEPC2 and USF2 genes by sequence comparison with the
corresponding cDNAs. The presence of splice donor and acceptor
sites £anking the alignment matches helped to predict the exact posi-
tions of exons.
2.4. RNA isolation and real-time reverse transcription-polymerase chain
reaction (RT-PCR) analysis
Total RNA was extracted from livers of iron-overloaded and con-
trol mice using SV total RNA isolation system (Promega, Charbon-
nie'res, France). Mouse BALB/c liver and pancreas poly(A)þ RNA
were purchased from Clontech Laboratories (Palo Alto, CA, USA).
cDNA ¢rst-strand synthesis was performed with Advantage RT-for-
PCR kit (Clontech, Palo Alto, CA, USA). A set of ¢rst-strand cDNAs
generated from di¡erent 8^12-week-old male BALB/c mice organs
and from whole embryos (Mouse Multiple Tissue cDNA Panel I)
was obtained from Clontech.
Primers and probes for real-time PCR analysis were designed with
the assistance of Primer Express Software (PE Biosystems). The fol-
lowing primers were selected to amplify HEPC1 and HEPC2: forward
for both HEPC1 and HEPC2, 5P-CCTATCTCCATCAACAGATG-
3P ; reverse for HEPC1 5P-AACAGATACCACACTGGGAA-3P and
reverse for HEPC2, 5P-AACAGATACCACAGGAGGGT-3P. To
avoid co-ampli¢cation of genomic DNA the designed forward
HEPC1 and HEPC2 primers overlapped exons I and II and reversed
primers positioned on exon III. The speci¢city of these primers was
demonstrated previously [5]. To amplify mouse L-actin we used the
following forward and reverse primers: 5P-GACGGCCAAGTCAT-
CACTATTG-3P and 5P-CCACAGGATTCCATACCCAAGA-3P, as
described by Dupic et al. [12]. To detect 171-bp mouse HEPC1 and
HEPC2, and 68-bp L-actin ampli¢cation products we used the follow-
ing probes: 5P-FAM-CCCTGCTTTCTTCCCCGTGCAAAG-TAM-
RA-3P and 5P-FAM-TACGAGGGCTATGCTCTCCCTCACGC-TA-
MRA-3P, respectively. The relative expression of HEPC1 and HEPC2
in the di¡erent samples was determined by standardization to its ex-
pression in normal adult mouse liver. For this purpose, we used a
two-step calculation method. First, for each sample, the Ctactin value
was subtracted from the corresponding CtHEPC to obtain normalized
vCt values. Then, these vCt values were used to calculate relative
levels of HEPC1 or HEPC2 expression as follows: HEPC expression
ratioðsample=referenceÞ =2vvCt, where vvCt= (vCtreference3vCtsample). The
HEPC1 and HEPC2 expression levels in adult normal liver were
used as reference and were set as 100% (Fig. 3) or as one-fold ex-
pression (Fig. 4). All quantitative real-time PCR assays were per-
formed in triplicate in a 96-well microplate using the qPCR1 Core
reagent kit (Eurogentec, Seraing, Belgium) and the ABI PRISM 7700
Sequence Detection System (PE Biosystems). For each microplate the
reactions contained target cDNAs, two standard curves prepared
from normal adult mouse liver cDNA and negative no-template con-
trol. PCR products were assessed by electrophoresis on 2% agarose
gel.
3. Results
3.1. Identi¢cation and nucleotide sequence of mouse HEPC2
cDNA
Careful analysis of mouse EST GenBank database revealed
the existence of two sets of highly homologous mice ESTs:
those identical to originally isolated HEPC1 cDNA [1] and a
set of ESTs showing approximately 85^92% identity and cor-
responding to HEPC2. One of these EST clones, IMAGE
clone 1889041 (EST AI255961) was completely sequenced.
This cDNA fragment was 406 bp in length and was found
to exhibit 92% identity with HEPC1 cDNA at the nucleotide
level (Fig. 1A). Similarly to HEPC1, HEPC2 cDNA contains
an open reading frame for the predicted polypeptide of 83 aa.
This hepcidin 2 proform exhibits 89% identity with prohepci-
din 1 at the amino acid level (Fig. 1B). The 58-aa N-terminal
part of hepcidin precursor 2 including the peptide signal se-
quence showed 98% identity with that of prohepcidin 1 with
perfect conservation of putative cleavage sites for furin-like
propeptide convertases. However, the 25-aa C-terminal pep-
tide corresponding to the putative mature chain of mouse
hepcidin 2 shares with hepcidin 1 only 68% identity (8 aa
from 25 are di¡erent). It is noteworthy that all 8 cysteine
residues in the 25-aa mature hepcidin 1 and hepcidin 2 pep-
tides are conserved.
Fig. 1. The nucleotide and predicted amino acid sequences of mouse
HEPC2. A: Alignment of full-length HEPC1 and HEPC 2 cDNAs.
Start and stop codons are shown in bold and polyadenylation sig-
nals in the 3P-untranslated region are indicated by thin underlining.
B: Alignment of hepcidin 1 and hepcidin 2 proteins. Sequences of
putative 25-aa mature peptides are boxed.
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3.2. Organization of HEPC1 and HEPC2 genes in the mouse
Previously, using the sequence information derived from
mouse genomic clone CT7-8N15 (GenBank accession number
AC020841) we determined that HEPC1 gene is composed of
three exons and two introns and is located on the chromo-
some 7 [1]. We have reexamined the genomic organization of
mouse HEPC1 and HEPC2 genes using sequence information
derived from several contigs of genomic clones CT7-8N15,
RP23-22G9 and RP23-28D21 (GenBank accession numbers
AC020841, AC087143 and AC021477, respectively) and pre-
viously reported partial nucleotide sequence of mouse USF2
gene [13]. Although sequence analysis of overlapping regions
of contigs from two distinct genomic clones CT7-8N15 and
RP23-22G9 revealed several discrepancies, we were able to
determine the following: (1) The HEPC1 and HEPC2 genes
co-localize on the same genomic clone. (2) The HEPC2 gene
comprises three exons and two introns and shares with the
HEPC1 gene a very high level of similarity (approximately
94% identity). The intron 2 of the HEPC2 gene but not of
HEPC1 contains insertion of several copies of simple tandem
repeat GAGAG (Fig. 2A). (3) 18 300-bp contig from genomic
clone RP23-22G9 includes full-length USF2 and HEPC2
genes lying in a tail-to-head orientation. (4) The HEPC1
gene lies directly downstream of the fragment of the USF2
gene encompassing exons 8^10 and a mouse retroviral intra-
cisternal A-particle (IAP) element inserted in the intron 7 of
the truncated USF2 gene (Fig. 2B). This IAP sequence pos-
sesses both 5P and 3P long terminal repeats.
3.3. Expression of HEPC1 and HEPC2 genes in mouse tissues
Because of the very high level of homology between HEPC1
and HEPC2 mRNA and similar lengths of transcripts, it was
not possible to study the speci¢c expression of corresponding
mRNAs by Northern blot analysis. Previous Northern blot
data most likely represented cumulative amounts of both
HEPC1 and HEPC2 transcripts. To assess the levels of
HEPC1 and HEPC2 mRNA expression, we developed a
quantitative real-time RT-PCR analysis using speci¢c primers
for HEPC1 and HEPC2 transcripts. To test the speci¢city of
the ampli¢cation reaction we used HEPC1 and HEPC2
cDNA. Neither HEPC1- nor HEPC2-speci¢c primers were
able to amplify DNA fragments using, respectively, 0.5 ng
of HEPC2 or HEPC1 cDNA as templates after 25 cycles
(data not shown), demonstrating a high speci¢city of the
PCR reaction.
The analysis of HEPC1 and HEPC2 gene expression in
eight mouse tissues including liver, spleen, skeletal muscles,
kidney and heart revealed that transcripts of both genes
were predominantly expressed in the liver and were weakly
detectable in the heart, skeletal muscles, lung and brain
(Fig. 3A). Additionally, we studied expression of HEPC1
Fig. 2. Genomic organization and location of mouse HEPC1 and
HEPC2 genes. A: Schematic representation of exon^intron organi-
zation of HEPC 1 and HEPC 2 genes. Exons are indicated as
boxes. Closed and open boxes correspond to coding and untrans-
lated regions, respectively. The lengths of exon and intron are
shown in bp. B: Genomic location of HEPC1, HEPC2 and USF2
genes on mouse chromosome 7. The lengths of genes and intergenic
regions are shown in bp. Arrows indicate the site of initiation and
direction of transcription.
Fig. 3. Expression of hepcidin genes in mouse adult and fetal tis-
sues. Amount of speci¢c HEPC1 and HEPC2 transcripts were deter-
mined by real-time RT-PCR analysis as described in Section 2. Rel-
ative levels of HEPC1 and HEPC2 gene expression in eight adult
mouse tissues (A), in adult liver and pancreas (B), and in whole
mouse embryos and in adult liver (C). Following RT-PCR, the
HEPC1, HEPC2 and L-actin ampli¢cation products were separated
on 2% agarose gel (lower panels).
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and HEPC2 genes in the liver and pancreas, two organs that
share a common embryonic origin, arising from the endome-
sodermal rudiment of foregut. We found that the HEPC1
gene was very weakly expressed in the pancreas. In contrast,
the amounts of hepcidin 2 transcripts in this tissue proved to
be at least nine times higher than that found in the liver (Fig.
3B). The speci¢city of the ampli¢cation reaction was con-
¢rmed by direct sequencing of PCR products obtained with
HEPC1 or HEPC2 primers.
The study of hepcidin gene expression during mouse fetal
development revealed that whole embryos contained very low
amounts of HEPC1 and HEPC2 transcripts and, in a general
manner, expression of both genes increased during develop-
ment (Fig. 3C).
3.4. Iron regulation of HEPC1 and HEPC2 genes
Previously we demonstrated by Northern blot analysis us-
ing mouse HEPC1 probe that the amounts of hepcidin tran-
scripts increased in the livers of mice overloaded by carbonyl^
iron or iron^dextran [1,14]. By quantitative real-time RT-PCR
we detected, respectively, a 4.7- and 5.8-fold increase of
HEPC1 and HEPC2 transcripts in the livers of carbonyl^
iron-overloaded mice. Similarly, liver expression of HEPC1
and HEPC2 genes was,respectively, 2.8 and 3.0 times higher
in iron^dextran-treated mice in comparison to the control
group (Fig. 4A,B).
4. Discussion
In this report we describe the mouse HEPC2 gene and
provide a comparative analysis of its genomic organization,
expression and iron regulation with that of the HEPC1 gene.
Previous transgenic mice experiments evidenced a central role
of hepcidin in iron metabolism. Speci¢cally, the absence of
both hepcidin transcripts was associated with iron-overload
phenotype [5]. In contrast, overexpression of HEPC1 cDNA
resulted in development of severe iron de¢ciency anemia [6].
Although it was not formally shown that hepcidin 2 has a
similar functional activity, it has been suggested that
HEPC1 and HEPC2 gene functions are redundant in the
mouse [5].
As a ¢rst step to understand the regulation and the role of
hepcidin 2, we isolated HEPC2 cDNA and demonstrated that
it shares a very high similarity with HEPC1 both at the nu-
cleotide and at the amino acid level in the corresponding
translated regions (92% and 89% identity, respectively). Inter-
estingly, although the positions of all eight cysteine residues
are conserved, the sequence of the 25-aa C-terminal part of
hepcidin 2 corresponding to the putative processed circulated
peptide is considerably divergent from that of hepcidin 1 with
only 68% identity, suggesting that these peptides could exhibit
di¡erent levels of iron-regulating activities.
In this study, we con¢rm and extend previous observations
that mouse genome contains two closely related HEPC genes
and that both of them are transcriptionally active. Careful
analysis of available mouse chromosome 7 genomic clones
suggests the following scenario of HEPC1 and HEPC2 gene
evolution: (1) duplication of a chromosome 7 region including
the HEPC ancestral gene and a part of the USF2 gene en-
compassing exons 8^10 and a fragment of a large intron 7 and
(2) insertion of the IAP element in the intron 7 of the trun-
cated USF2 gene in the duplicated genomic region. The sim-
ilar exon^intron organization, high conservation between
HEPC1 and HEPC2 genes and the presence of only one
HEPC gene in the human and rat genomes indicate that
this duplication has likely occurred very recently.
The IAP sequence, located upstream of the HEPC1 gene, is
a member of retrovirus-like mobile elements presented at ap-
proximately 1000 copies in the mouse genome [15]. IAP trans-
position frequently resulted in either inactivation or activation
of adjacent genes [16]. In addition, retrotransposition of sev-
eral IAP-like elements is frequently strain-speci¢c, provoking
modulation of gene expression activities only in certain strains
of mouse [17]. Taking into consideration these observations,
we cannot exclude that IAP transposition could also have an
in£uence on hepcidin expression and iron homeostasis in a
strain-speci¢c manner. Indeed, di¡erent mouse strains exhibit
variability in several parameters of iron metabolism including
basal serum iron levels and hepatic iron stores [18]. In addi-
tion, heritable factors in£uence considerably iron homeostasis
in response to HFE (the gene mutated in the common form of
hereditary hemochromatosis) or L2-microblobulin gene dis-
ruption [12,19,20]. Therefore, it is tempting to speculate that
hepcidin could contribute, at least partly, to strain-speci¢c
variability of basal iron status and sensitivity to iron overload.
An interesting ¢nding of this study is the demonstration of
a high amount of HEPC2 transcripts in the pancreas. Pres-
ently the molecular mechanisms that control pancreatic ex-
pression of hepcidin 2 are unknown. Alignment of 800-bp
5P-£anking regions of HEPC 1 and HEPC2 genes revealed a
very high level of similarity (92% identity). The HEPC2 gene
5P-£anking regions contains all putative binding sites for tran-
scription factors including C/EBP and HNF4 that have been
previously identi¢ed in the HEPC1 promoter [14].
Collectively, HEPC1 and HEPC2 genes are expressed essen-
tially in the liver, pancreas and at much lower levels in the
heart. Interestingly, the liver and the pancreas were the prin-
cipal iron-overloaded organs in USF2 (3/3) mice lacking
hepcidin transcript expression. Substantial iron accumulation
was also observed in the heart [5]. Accumulation of iron in the
liver, pancreas and heart was also described in several other
rodent models of iron overload including those experimentally
provoked [21,22] and in genetic iron overload [23,24]. This
striking parallelism between expression of hepcidin transcripts
Fig. 4. Iron-mediated induction of HEPC1 and HEPC2 genes. The
amounts of speci¢c HEPC1 and HEPC2 transcripts were determined
by real-time RT-PCR analysis as described in Section 2. Relative
changes of HEPC1 and HEPC2 gene expression in the livers of (A)
carbonyl^iron- and (B) iron^dextran-overloaded mice. The relative
level of HEPC1 and HEPC2 transcript expression is indicated above
the bars.
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and localization of iron deposits during iron overload suggests
that in addition to the proposed humoral role of hepcidin in
regulation of intestinal iron absorption and macrophage iron
release, it could be involved in the local control of cellular
iron store in the liver and pancreas. Finally, we demonstrated
that both HEPC1 and HEPC2 genes were strongly up-regu-
lated in the liver by iron excess.
In conclusion, our data suggests that both HEPC1 and
HEPC2 genes are involved in the regulation of iron metabo-
lism. However, we do not exclude that hepcidin 1 and hepci-
din 2 could play distinct roles and/or exhibit di¡erent physio-
logical activities. Further studies including selective ablation
of HEPC1 or HEPC2 genes will be necessary to resolve this
issue.
Acknowledgements: This work was supported by Le Conseil Re¤gional
de Bretagne, European Community Grant QLK1-CT-25002-00444,
La Ligue Contre le Cancer Comite¤ d’Ille et Vilaine and L’Association
Fer et Foie.
References
[1] Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B.,
Brissot, P. and Loreal, O. (2001) J. Biol. Chem. 276, 7811^7819.
[2] Krause, A., Neitz, S., Magert, H.J., Schulz, A., Forssmann,
W.G., Schulz-Knappe, P. and Adermann, K. (2000) FEBS
Lett. 480, 147^150.
[3] Park, C.H., Valore, E.V., Waring, A.J. and Ganz, T. (2001)
J. Biol. Chem. 276, 7806^7810.
[4] Hunter, H.N., Fulton, D.B., Ganz, T. and Vogel, H.J. (2002)
J. Biol. Chem. 277, 37597^37603.
[5] Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grand-
champ, B., Kahn, A. and Vaulont, S. (2001) Proc. Natl. Acad.
Sci. USA 98, 8780^8785.
[6] Nicolas, G. et al. (2002) Proc. Natl. Acad. Sci. USA 99, 4596^
4601.
[7] Fleming, R.E. and Sly, W.S. (2001) Proc. Natl. Acad. Sci. USA
98, 8160^8162.
[8] Weinstein, D.A., Roy, C.N., Fleming, M.D., Loda, M.F., Wolfs-
dorf, J.I. and Andrews, N.C. (2002) Blood 100, 3776^3781.
[9] Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli,
D., Christakis, J., Loukopoulos, D. and Camaschella, C. (2003)
Nat. Genet. 33, 21^22.
[10] Andrews, N.C. (2000) Nat. Rev. Genet. 1, 208^217.
[11] Pigeon, C., Turlin, B., Iancu, T.C., Leroyer, P., Le Lan, J.,
Deugnier, Y., Brissot, P. and Loreal, O. (1999) J. Hepatol. 30,
926^934.
[12] Dupic, F. et al. (2002) Gastroenterology 122, 745^751.
[13] Lin, Q., Luo, X. and Sawadogo, M. (1994) J. Biol. Chem. 269,
23894^23903.
[14] Courselaud, B. et al. (2002) J. Biol. Chem. 277, 41163^41170.
[15] Ku¡, E.L. and Lueders, K.K. (1988) Adv. Cancer Res. 51, 183^
276.
[16] Ku¡, E.L. (1990) Cancer Cells 2, 398^400.
[17] Chang-Yeh, A., Mold, D.E., Brilliant, M.H. and Huang, R.C.
(1993) Proc. Natl. Acad. Sci. USA 90, 292^296.
[18] Leboeuf, R.C., Tolson, D. and Heinecke, J.W. (1995) J. Lab.
Clin. Med. 126, 128^136.
[19] Fleming, R.E. et al. (2001) Proc. Natl. Acad. Sci. USA 98, 2707^
2711.
[20] Sproule, T.J., Jazwinska, E.C., Britton, R.S., Bacon, B.R., Flem-
ing, R.E., Sly, W.S. and Roopenian, D.C. (2001) Proc. Natl.
Acad. Sci. USA 98, 5170^5174.
[21] Iancu, T.C., Ward, R.J. and Peters, T.J. (1987) Virchows Arch.
Cell. Pathol. Incl. Mol. Pathol. 53, 208^217.
[22] Pelot, D., Zhou, X.J., Carpenter, P. and Vaziri, N.D. (1998) Dig.
Dis. Sci. 43, 2411^2414.
[23] Iancu, T.C., Shiloh, H., Raja, K.B., Simpson, R.J., Peters, T.J.,
Perl, D.P., Hsu, A. and Good, P.F. (1995) J. Pathol. 177, 83^94.
[24] Santos, M.M., de Sousa, M., Rademakers, L.H., Clevers, H.,
Marx, J.J. and Schilham, M.W. (2000) Am. J. Pathol. 157,
1883^1892.
FEBS 27171 22-4-03
G. Ilyin et al./FEBS Letters 542 (2003) 22^2626
